Literature DB >> 25483436

Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC.

K D Williamson1, R W Chapman.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25483436     DOI： 10.1111/apt.13004

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  5 in total

1.  Clinical and laboratory parameters associated with li-rads as diagnostic of liver nodule in patients with cirrhosis.

Authors:  Clarissa Rocha Cruz; Ana Rita Marinho Ribeiro Carvalho; Augusto César Nascimento Maranhão; Dayse Barbosa Aroucha; Gabriela Azevedo Foinquinos; Sylene Rampche Coutinho Carvalho; Luydson Richardson Silva Vasconcelos; Leila Maria Moreira Beltrão Pereira
Journal:  Transl Gastroenterol Hepatol       Date:  2021-10-25

2.  Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.

Authors:  S Keller; J Sedlacik; T Schuler; R Buchert; M Avanesov; R Zenouzi; A W Lohse; H Kooijman; J Fiehler; C Schramm; J Yamamura
Journal:  Eur Radiol       Date:  2018-07-16       Impact factor: 5.315

3.  Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.

Authors:  Xiurong Cai; Zhanhong Chen; Jie Chen; Xiaokun Ma; Mingjun Bai; Tiantian Wang; Xiangwei Chen; Donghao Wu; Li Wei; Xing Li; Qu Lin; Jingyun Wen; Danyun Ruan; Zexiao Lin; Min Dong; Xiangyuan Wu
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

Review 4.  The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Authors:  Kate D Lynch; Satish Keshav; Roger W Chapman
Journal:  Curr Hepatol Rep       Date:  2019-03-07

5.  Derivation and external validation of a model to predict 2-year mortality risk of patients with advanced schistosomiasis after discharge.

Authors:  Guo Li; Shanshan Huang; Lifei Lian; Xiaoyan Song; Wenzhe Sun; Jinfeng Miao; Bohan Li; Yong Yuan; Shengfan Wu; Xiaoyan Liu; Zhou Zhu
Journal:  EBioMedicine       Date:  2019-08-23       Impact factor: 8.143
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.